By contrast, in cancer patients, the KP is deregulated, resulting in local tryptophan depletion and overproduction of active metabolites, which leads to the formation of an immunosuppressive tumor microenvironment (Figure 3) [49,67]. The gene discussed is NPPA; the disease is cancer.